Best Americanheartassociation Podcasts (2024)

1
Episode 20: You Wouldn’t Risk It – Pharmacologic considerations for anticoagulant therapy in Afib patients 14:35

8d ago14:35

14:35

This episode explores current guideline recommendations for anticoagulant use in Afib patients, factors that contribute to undertreatment, and common drug interactions to be considered in anticoagulated Afib patients who are being treated in other disease care settings.By American Heart Association

1
Episode 19: You Wouldn’t Risk It – Overcoming patient barriers to ensure access to anticoagulant therapy 20:14

15d ago20:14

20:14

This week's episode will take a closer look at the common barriers to anticoagulant therapy in Afib patients. We will examine strategies to support shared decision making, patient education, and navigating those crucial conversations to overcome patient refusal of guideline directed therapy.By American Heart Association

1
Episode 18: You Wouldn’t Risk It – Workflows ensuring care continuity from patient admission to EP consult 12:48

22d ago12:48

12:48

This week's episode will delve into the complex workflows within a health system and how they be a help or a hinderance to an AFib patient once they are discharge. Our guest will demonstrate effective strategies that allow collaboration both within the hospital as well as with external clinics to ensure that care management does not end at discharg…

1
Episode 17: You Wouldn’t Risk It – Creating a culture of quality through education in the staffing process 22:01

29d ago22:01

22:01

This week's episode provides a roadmap for creating a culture of high-quality Afib care within a health system. We'll discuss the importance of anticoagulant therapy and Afib management education outside of the electrophysiology and cardiology teams, how this education is reflected in other care settings, and how this can be replicated.…

1
AHA HCM Clinical Update: 2024 Guideline for Management of Hypertrophic Cardiomyopathy 1:05:24

1M ago1:05:24

1:05:24

In this On Demand video, Dr. Steve Ommen and Dr. Carolyn Ho discuss recent updates to the 2024 Guideline for the Management of Hypertrophic Cardiomyopathy (HCM). Watch now to enhance your knowledge on the importance of shared decision-making, the use of cardiac myosin inhibitors to treat symptomatic obstructive HCM, and risk stratification for atri…

1
Episode 16: You Wouldn’t Risk It – Leveraging your EHR systems to improve medication education 20:39

1M ago20:39

20:39

This week's episode provides insight into the process of successfully implementing an EHR solution within a health system with the goal of improving medication education for anticoagulant therapy in Afib patients. We will team pharmacy's role, workflows, dosing, monitoring, and education tracking.By American Heart Association

1
Episode 15: The 4 F’s of Atrial Fibrillation – Forgetfulness 20:37

2M ago20:37

20:37

The 4 F's of AFib addresses gaps and barriers to care for the diagnosed and undertreated AFib patient around four key areas of concern - Frailty, Falls, Fear or Bleeding, and Forgetfulness.By American Heart Association

1
Episode 14: The 4 F’s of Atrial Fibrillation – Falls 13:51

2M ago13:51

13:51

The 4 F's of AFib addresses gaps and barriers to care for the diagnosed and undertreated AFib patient around four key areas of concern - Frailty, Falls, Fear or Bleeding, and Forgetfulness.By American Heart Association

1
Episode 13: The 4 F’s of Atrial Fibrillation – Frailty 16:23

2M ago16:23

16:23

The 4 F's of AFib addresses gaps and barriers to care for the diagnosed and undertreated AFib patient around four key areas of concern - Frailty, Falls, Fear or Bleeding, and Forgetfulness.By American Heart Association

1
Episode 12: The 4 F’s of Atrial Fibrillation – Fear of Bleeding 12:58

2M ago12:58

12:58

The 4 F's of AFib addresses gaps and barriers to care for the diagnosed and undertreated AFib patient around four key areas of concern - Frailty, Falls, Fear or Bleeding, and Forgetfulness.By American Heart Association

1
Episode 11: Pharmacologic Management of ASCVD 16:06

4M ago16:06

16:06

This episode explores the medications involved in treating hyperlipidemia-related ASCVD from a pharmacist perspective and the common patient misconceptions surrounding these interventions. Speaker: Megan Supple, PharmD, BCACP, CPP Ambulatory Care Pharmacist Cone Health Medical Group Cardiovascular Division…

1
Episode 10: Primary Prevention Insights into Patient Reported ASCVD Barriers 27:39

4M ago27:39

27:39

This episode examines the most common patient perceived barriers to treatment and management strategies to overcome these situations in the outpatient/clinic setting. Speaker: Kevin Hwang, MD Associate Professor of Internal Medicine at McGovern Medical School Medical Director, UT General Internal Medicine clinic in the Texas Medical Center…

1
Episode 9: ASCVD Management in the ED 20:18

4M ago20:18

20:18

This episode evaluates pathways to identify adults with high ASCVD risk and intervention with lipid-lowering therapy in the Emergency Department. Speaker: James Langabeer, MD Professor of Emergency Medicine Vice Chair- Population HealthBy American Heart Association

1
Episode 8: Roadmap to ASCVD Treatment 20:39

4M ago20:39

20:39

This episode lays the groundwork for our understanding of ASCVD lipid management. Our guest will walk through the algorithm for treatment to guidelines as well as address the barriers, pitfalls, and potential solutions in managing care. Speaker: Dr. Murtuza Ali ,MD Professor of Clinical Medicine Program Director- Interventional Cardiology Fellowshi…

1
Episode 7: Tackling ASCVD Through Lifestyle Modifications 13:32

4M ago13:32

13:32

Julia Zumpano, a Registered Dietician meets with Kattia to discuss her ASCVD and the effects that her diet and exercise can improve and further prevent future events.By American Heart Association

1
Episode 6: What it Means to Have ASCVD 18:43

4M ago18:43

18:43

Dr. Kevin Hwang meets with a patient, Levi, who was recently discharged from the hospital after going to the E.R. with chest pain. In the E.R., they did some EKGs and blood work and diagnosed him with a heart attack. Also, they did a cardiac catheterization, where they found blockages in his arteries, ultimately putting a stent in one of them. Fina…

1
Episode 5: Managing & Understanding Cholesterol for ASCVD 18:04

4M ago18:04

18:04

Carolyn Dickens, a nurse practitioner that works in cardiology, speaks with Ms. Sharma who recently had a heart attack and is seeking help with making healthier choices as she learns to live with the impact of ASCVD.By American Heart Association

1
Episode 4: Patient Provider Relationships 12:37

4M ago12:37

12:37

Our patient Rob, who has been diagnosed with ASCVD, pays a visit to Dr. Salazar to learn more about the patient health care journey he is about to embark upon.By American Heart Association

1
Episode 3: The Next Top Model Activating and Improving Systems of Care 26:47

4M ago26:47

26:47

Listen as Dr. Howard Haft & Dr. Tracy Yu-Ping Wang discuss techniques on how to improve the transition of care for ASCVD patients into the outpatient setting – and how social determinants of health play a factor in treatment plans.By American Heart Association

1
Episode 2: Looking Ahead in ASCVD 17:10

4M ago17:10

17:10

One of the biggest challenges for newly diagnosed ASCVD patients is medication adherence. Listen as Dr. Michelle Chu, PharmD discusses how to work with patients who are struggling to adapt to their new lifestyle and the importance of integrating their care givers into the conversation. One of the biggest challenges for newly diagnosed ASCVD patient…

1
Episode 1: The importance of bridging the gap in lipid management 20:21

4M ago20:21

20:21

How does the equity gap play a role in lipid management? Join us as we interview Dr. Keith Ferdinand on the importance of recognizing & addressing implicit bias in cardiovascular care, and what he is doing at Tulane university to train future physicians in this subject matter.By American Heart Association

1
The Renaissance of Renal Denervation 30:02

11M ago30:02

30:02

Resistant hypertension affects twenty percent of all hypertensive patients. It is the source of much cardiovascular risk and its ultimate sequela. To this end innovative mechanisms of addressing this problem have and are being developed. One of these is renal denervation of the sympathetic system. Our guests on the podcast compare clinical studies …

1
Team-based Hypertension Care in the Clinic: A Success Story 25:49

11M ago25:49

25:49

Managing hypertension is complex as you consider aspects of taking multiple medications, making lifestyle changes with diet and physical activity, and learning self-monitoring of blood pressure at home. As supported by guideline recommendations, team-based care among multidisciplinary healthcare professionals is important to optimize blood pressure…

1
Lifestyle: Decisions for Daily Life 33:36

11M ago33:36

33:36

Weight management, physical activity, and a heart-healthy diet are key behaviors in managing blood pressure and essential to lifelong good health. What role do clinicians play in shared decision making discussions with hypertensive patients around daily lifestyle decisions. What steps can clinicians take in providing guideline informed hypertension…

1
Home Blood Pressure Monitoring with Clinical Support 23:29

11M ago23:29

23:29

Home blood pressure monitoring is informative but inaccessible for some outside of strengthened clinical support. Current guidelines comprehensively address how to define, measure, and treat high blood pressure, and yet hypertension management in special patient populations has not been systematically addressed. Listen and learn how clinicians can …

1
Shared Decision-Making and Adherence 33:11

11M ago33:11

33:11

While patients may have different goals and preferences for treatment, which can make selecting the best hypertension management plan difficult, adherence may be increased if the plan aligns with the patient’s preferences. What approaches in shared decision-making may improve adherence? In this episode clinicians and a patient discuss changes in te…

1
Chronic Coronary Disease Guideline

12M ago

—

Dr. Salim Virani, professor of medicine at Aga Khan University and cardiologist at Texas Heart Institute, and Dr. Kristin Newby, professor of medicine at the Duke University School of Medicine, served together as co-chairs for the 2023 American Heart Association and American College of Cardiology Guideline for Chronic Coronary Disease. These guidel…

1
Drugs or Devices for the Resistant Hypertensive Patient 50:15

1+ y ago50:15

50:15

Renal denervation in the management of hypertension in adults has yet to be approved in the US, however, it is under FDA review. This procedure may be useful for adults with uncontrolled or resistant hypertension (triple drug therapy, one of which is a diuretic) and may be an option for patients unable to tolerate long-term medications at the neces…

1
Needle in the Haystack? Screening Large Populations for HCM 30:31

2y ago30:31

30:31

It is estimated that 1 in every 500 adults living in the U.S. have HCM, but a large percentage of patients are undiagnosed. Listen to this podcast to gain insight into hypertrophic cardiomyopathy (HCM) screening and what it means to your patients.By American Heart Association

1
ASCVD Series - Part 3-The Next Top Model: Activating & Improving Systems of Care 25:46

2y ago25:46

25:46

Listen as Dr. Howard Haft & Dr. Tracy Yu-Ping Wang discuss techniques on how to improve the transition of care for ASCVD patients into the outpatient setting – and how social determinants of health play a factor in treatment plans.

1
ASCVD Series - Part 2-Looking Ahead in ASCVD 16:18

2y ago16:18

16:18

One of the biggest challenges for newly diagnosed ASCVD patients is medication adherence. Listen as Dr. Michelle Chu, PharmD discusses how to work with patients who are struggling to adapt to their new lifestyle and the importance of integrating their care givers into the conversation.

1
ASCVD Series - Part 1-The Importance of Bridging the Gap in Lipid Management 19:29

2y ago19:29

19:29

How does the equity gap play a role in lipid management? Join us as we interview Dr. Keith Ferdinand on the importance of recognizing & addressing implicit bias in cardiovascular care, and what he is doing at Tulane University to train future physicians in this subject matter.

1
HCM and New Pharmacological Agents 37:25

2y ago37:25

37:25

Making the correct of hypertrophic cardiomyopathy (HCM) is critical in being able to initiate early surveillance and therapy to improve patient outcomes. In this podcast focusing on pharmacologic treatment options, learn more about completed and ongoing myosin inhibitor clinical trials.By American Heart Association

1
Beware! Phenocopies of Hypertrophic Cardiomyopathy 34:26

2y ago34:26

34:26

Accurate diagnosis of Hypertrophic Cardiomyopathy (HCM) is critical. HCM is a chronic and progressive disease putting patients at risk of serious complications and co-morbidities. Early and correct detection may help reduce some of the consequences of HCM and improve outcomes. In this podcast, learn more about how to distinguish phenocopies from HC…

1
The Role of Echocardiography in the Diagnosis and Management of Patients with Hypertrophic Cardiomyopathy 28:54

2y ago28:54

28:54

Diagnosis of hypertrophic cardiomyopathy is typically done by echocardiogram to assess the thickness of the heart muscle and observe blood flow in and out of the heart. In this podcast, learn more about how echocardiography is used in the diagnosis, screening, and management of HCM.By American Heart Association

1
Hypertrophic Cardiomyopathy, not just an adult disease: the pediatric perspective 31:24

2+ y ago31:24

31:24

Hypertrophic cardiomyopathy (HCM) is the most common form of inherited heart disease and can affect people of any age. In this episode, learn what causes hypertrophic cardiomyopathy in children and the clinical and genetic screening needed to diagnosis HCM.By American Heart Association

1
Exercising with Hypertrophic Cardiomyopathy (HCM) 31:29

2+ y ago31:29

31:29

Although the cardiovascular and overall health benefits of regular activity are well-established, recommendations for recreational exercise and competitive sports participation for patients with HCM have been challenging. Listen to this podcast as Drs. Abraham, Day, and Martinez along with Brian Metz discuss exercising with HCM and the importance o…

1
Hypertrophic Cardiomyopathy – Genetic Counseling and Family Screening 26:56

3y ago26:56

26:56

Hypertrophic cardiomyopathy (HCM) is the most common form of genetic heart disease and can affect people of any age, yet it often goes undiagnosed. Genetic testing and counseling plays an important role in the diagnosis and management of HCM in patients in families. Learn more about genetic testing and counseling, and its impact on the patient’s fa…

1
Hypertrophic Cardiomyopathy and Atrial Fibrillation 20:33

3y ago20:33

20:33

People with HCM are at increased risk for developing arrythmias such as atrial fibrillation, suffering from stroke and even sudden cardiac arrest. People with HCM face a risk of death more than 3 times greater than the average person of the same age without HCM. Learn more about the complex relation between atrial fibrillation and hypertrophic card…

1
Cardiac Transplantation and New Frontiers in Hypertrophic Cardiomyopathy 47:19

3y ago47:19

47:19

Surgical and interventional options such as surgical myectomy or alcohol septal ablation may help those with obstructive Hypertrophic Cardiomyopathy (HCM) to reduce or remove the obstruction. A similar option is unavailable to those with non-obstructive HCM. Heart transplants are considered as a last resort for HCM patients who progress to end stag…

1
Statin and Non-Statin Drugs 37:40

3y ago37:40

37:40

Statins are the cornerstone of lipid lowering drugs. Listen as Drs. Natarajan, Michos, and Kara discuss the role of statins for cardiovascular disease prevention as well as new incorporation of some non-statin cholesterol-lowering medications in 2018 AHA/ACC Cholesterol Guidelines.By American Heart Association

1
Coronary Calcification (CAC Score) 47:14

3y ago47:14

47:14

A deep dive discussion between Drs. Pradeep Natarajan, Ron Blankstein and Khurram Nasir in assessment of Coronary artery calcium (CAC) to help guide prognosis and management. In this podcast learn the role of CAC score.By American Heart Association

1
Uses of PCSK9 Inhibitors 20:35

3y ago20:35

20:35

Listen as Drs. Ferguson and Musunuru review history and uses of PCSK9 inhibitors and how these drugs can transform cardiovascular medicine.By American Heart Association

1
New Discoveries in Cholesterol Metabolism 25:06

3y ago25:06

25:06

Despite medications to reduce risk of heart cardiovascular disease; heart disease is still the number one leading cause of death in the United States as well as around the world. Listen to Drs. Ferguson and Musunuru as they review new discoveries in cholesterol metabolism and explore why researchers are continuing to study cholesterol metabolism ve…

1
ASCVD Risk Calculator 28:52

3y ago28:52

28:52

Atherosclerotic Cardiovascular Disease (ASCVD). risk calculator is a tool that enables healthcare providers and patients to estimate ten-year and lifetime risk of ASCVD. Listen as Dr. Virani explores the reasons why should healthcare professionals should perform ASCVD risk assessment and how the ASCVD Risk Calculator can be used.…

1
Familial Hypercholesterolemia 22:57

3y ago22:57

22:57

What is the prevalence of familial hypercholesterolemia? Learn more as Drs. Mehta and Orringer examine the 2018 cholesterol guidelines and how familial hypercholesterolemia and its treatment fall into the new guideline.By American Heart Association

1
Women’s CVD and the Cholesterol Guidelines 22:15

3y ago22:15

22:15

Cardiovascular disease is the leading cause of death for women in the US and worldwide. Listen as Drs. Mehta, Braun, and Lundberg discuss the importance of adding women-specific factors in the guideline and focus on many important areas common in women’s health that includes rheumatologic disorders, such as rheumatoid arthritis, systemic lupus eryt…

1
New Guideline Changes 18:15

3y ago18:15

18:15

The 2018 AHA/ACC cholesterol guideline address the management of patients with high blood cholesterol and other disorders, and risks for atherosclerotic cardiovascular disease. Listen as Dr. Pradeep Natarajan discusses the important changes in 2018 AHA/ACC Cholesterol Guidelines and comparing them to the 2013 cholesterol guideline.…

1
Hypertrophic Cardiomyopathy: Diagnosis and Clinical Implications of Structural Phenotypes 36:07

3y ago36:07

36:07

The American Heart Association is committed to being your resource for diagnosing and treating patients with hypertrophic cardiomyopathy (HCM). Listen today to Hypertrophic Cardiomyopathy: Diagnosis and Clinical Implications of Structural Phenotypes.By American Heart Association

1
Hypertrophic Cardiomyopathy - Invasive Strategies: Percutaneous and Surgical 20:57

3y ago20:57

20:57

Invasive Strategies: Percutaneous and Surgical is a discussion on hypertrophic cardiomyopathy exploring invasive strategies for patients with HCM, including both percutaneous and surgical approaches.

Podcasts Worth a Listen

Americanheartassociation Podcasts

Podcasts Worth a Listen

Quick Reference Guide